title: Aortic revascularization of orthotopic liver allografts: indications and long-term follow-up.
abstract: BACKGROUND
  Occasionally because of certain conditions that would imperil arterial supply to a hepatic graft, it is necessary to base the arterial supply on the aorta.
  
  
  METHODS
  Twenty orthotopic liver transplants (OLTs) in 19 patients were performed with arterial revascularization based on the aorta (Ao-OLT). In two patients the donor celiac axis was anastomosed directly to the aorta and in 18 to a conduit anastomosed to either the supraceliac (n = 10) or infrarenal (n = 8) aorta.
  
  
  RESULTS
  One thrombosis occurred 2 months after the placement of a supraceliac conduit in an adult patients, accounting for a cumulative 1-year hepatic artery patency rate of 91.7% +/- 8.0% for 16 grafts placed in 15 adults and 100% for four grafts placed in four children. In comparison, hepatic artery-based transplantation was associated with a 1-year patency rate of 92.6% +/- 1.9% for 245 adults and 94.7% +/- 5.1% for 19 children (difference not significant compared with Ao-OLT). By logistic regression analysis, the only factor independently associated with hepatic artery thrombosis was retransplantation (1-year hepatic artery patency rate 85.7% +/- 5.9% [n = 38] for retransplants vs 93.9% +/- 1.7% for primary transplantation [n = 246]; p < 0.05). For retransplantation, Ao-OLT revascularizations were superior to those based on the hepatic artery (1-year patency rate 100% [n = 11] vs 79.9% +/- 8.1% [n = 27]; p < 0.05).
  
  
  CONCLUSIONS
  Indications for Ao-OLT include poor hepatic arterial inflow, small or anomalous recipient hepatic arteries, friable or attenuated native hepatic arteries as may be present during retransplantation, and recipient age less than 1 year, especially those less than 15 kg or in whom the recipient artery is less than 3 mm in diameter. In these more precarious situations, Ao-OLT achieves patency rates similar to those of primary, uncomplicated OLT, is superior for retransplantation, and has technical advantages in the small pediatric liver recipient.
authors.affiliation: Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0331.
authors.forename: H A
authors.initials: HA
authors.lastname: Hennein
authors.forename: E N
authors.initials: EN
authors.lastname: Mendeloff
authors.forename: J G
authors.initials: JG
authors.lastname: Turcotte
authors.forename: J M
authors.initials: JM
authors.lastname: Ham
authors.forename: P
authors.initials: P
authors.lastname: Baliga
authors.forename: D A
authors.initials: DA
authors.lastname: Campbell
authors.forename: R M
authors.initials: RM
authors.lastname: Merion
mesh_terms: D000293:Adolescent; D000328:Adult; D000704:Analysis of Variance; D000714:Anastomosis, Surgical; D001011:Aorta / Q000601:surgery*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006499:Hepatic Artery / Q000601:surgery; D006801:Humans; D007083:Iliac Artery / Q000601:surgery; D015993:Life Tables; D016031:Liver Transplantation / Q000009:adverse effects / Q000379:methods*; D016015:Logistic Models; D008297:Male; D013927:Thrombosis / Q000209:etiology